SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Array Biopharma, Inc
ARRY 8.660+3.2%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche7/28/2015 2:54:54 PM
   of 321
 
When I look at the chart, I see what must be a dream situation for those who trade (sell) on technicals....... a series of lower lows, filling a gap with downside momentum.

Whompo selling pressure today, as LOXO is up 25%. ARRY gets hefty biobucks for LOXO-101 milestones and biobuck LOXO-101 royalties. Last report that I've seen (LOXO def14a?), ARRY still owned ~6%.

ARRY currently down 3% on day, just tested it..... more shares on ask (5.83) than are showing.

edit: I was competing over the weekend, and flew out to Washington State last week oblivious of selumetinib news. There is also a pointer at twitter to a terminated MEK162 trial, same indication.... uveal melanoma.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News